Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Association of Short-Acting-β-2 Agonist (SABA) Overuse and Risk of COPD among Adult Asthma Patients

M Asamoah-Boaheng, J Farrell, K O Bonsu, W K Midodzi
European Respiratory Journal 2022 60: 3409; DOI: 10.1183/13993003.congress-2022.3409
M Asamoah-Boaheng
1Faculty of Medicine, Memorial University of Newfoundland, St John's, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Farrell
1Faculty of Medicine, Memorial University of Newfoundland, St John's, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K O Bonsu
2School of Pharmacy, Memorial University of Newfoundland, St John's, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W K Midodzi
1Faculty of Medicine, Memorial University of Newfoundland, St John's, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 60 no. suppl 66
DOI 
https://doi.org/10.1183/13993003.congress-2022.3409

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online December 1, 2022.

Copyright & Usage 
Copyright ©the authors 2022

Author Information

  1. M Asamoah-Boaheng1,
  2. J Farrell1,
  3. K O Bonsu2 and
  4. W K Midodzi1
  1. 1Faculty of Medicine, Memorial University of Newfoundland, St John's, Canada
  2. 2School of Pharmacy, Memorial University of Newfoundland, St John's, Canada

Article usage

Article usage: December 2022 to February 2023

AbstractFullPdf
Dec 20223600
Jan 20232100
Feb 20231600

Altmetrics

Previous
Back to top
Vol 60 Issue suppl 66 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Association of Short-Acting-β-2 Agonist (SABA) Overuse and Risk of COPD among Adult Asthma Patients
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Association of Short-Acting-β-2 Agonist (SABA) Overuse and Risk of COPD among Adult Asthma Patients
M Asamoah-Boaheng, J Farrell, K O Bonsu, W K Midodzi
European Respiratory Journal Sep 2022, 60 (suppl 66) 3409; DOI: 10.1183/13993003.congress-2022.3409

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Association of Short-Acting-β-2 Agonist (SABA) Overuse and Risk of COPD among Adult Asthma Patients
M Asamoah-Boaheng, J Farrell, K O Bonsu, W K Midodzi
European Respiratory Journal Sep 2022, 60 (suppl 66) 3409; DOI: 10.1183/13993003.congress-2022.3409
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • RCT Abstract - Airway smooth muscle mass to predict response to ICS in COPD patients receiving triple therapy (HISTORIC study): a randomized, placebo-controlled, double-blind, investigator-initiated trial
  • Bronchodilators in Symptomatic Tobacco-exposed Persons with Preserved Spirometry for the RETHINC Study Group
  • Dose response of icenticaftor in patients with COPD and chronic bronchitis on triple inhaled therapy
Show more 05.01 - Airway pharmacology and treatment

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society